Biomarkers In Drug Discovery - Optimizing Drug Discovery Timeline And Costs - Aarkstore Enterprise

Aarkstore announce a new report "Biomarkers in Drug Discovery - Optimizing Drug

Discovery Timeline and Costs" through its vast collection of market research report.

Summary

The leading business intelligence provider, has released its latest research, Biomarkers In Drug Discovery - Optimizing Drug Discovery Timeline and Costs. The report provides an in-depth analysis of the potential applications of biomarkers in pharmaceutical drug discovery and clinical services. This pharmaceutical and healthcare report suggests investment decisions in biomarker-based drug research by providing information on valid biomarkers, pipelines, case studies, competitive landscape, geographical trends, mergers and acquisitions and market potential. It also provides an analysis on the trends prevailing in the global biomarkers market. In addition to this, the report covers drivers and restrains for the global biomarkers market.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

Scope

The scope of this report includes:

- Market Potential and Pipeline Analysis of biomarkers by phase of development, therapeutic class and geography.

- Market Size and forecast of global biomarkers market and biomarkers drug discovery market from 2000 to 2008, forecast forward to 2015.

- Analysis of Key geographies including the US (United States), Europe the UK (United Kingdom), France, Germany, Italy and Spain), Australia and Southeast Asia.

- Investments and Funding Analysis for top companies (Quest Diagnostics, Applied Biosystems, Vermillion, BGMedical, Menarini, Abbott, Roche, Genetech, Affymetrix and Amgen) in the biomarker-based assay development arena. This includes biomarker research on the application and development of novel biomarkers by the top companies and analysis of the competitive factors affecting the global biomarkers market.

- Qualitative analysis of market drivers, market trends, and challenges.

- M&A landscape in the biomarkers space segmented by deal value, geography and phase.

Reasons to buy

The report will improve decision making and will enable you to:

- Develop business strategies by understanding the trends and developments that are driving the biomarkers-based drug research and development.

- Design, develop and expand your product development, marketing and sales strategies based on forecast of global biomarkers and biomarkers drug discovery market till 2015

- Develop business strategies to exploit biomarkers-based drug discovery market in emerging geographies

- Identify the key players positioned to take advantage of the emerging market opportunities

- Exploit M&A opportunities by identifying key market players with the most novel pipeline

For more information, please visit:

http://www.aarkstore.com/reports/Biomarkers-in-Drug-Discovery-Optimizing-Drug-Discovery-Timeline-and-Costs-37289.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise

POST COMMENT

Cat Allergy Medicine Drug Discovery In India And China - Aarkstore Enterprise Offshore Medical Transcription - Used By Many Medical Stock Update On Avii, Alxn And Prot From Pennytobuck.com Drug Metabolism Celexa Drug Medical Alert System What Drug Companies Don't Want You To Know: Natural Remedies For High Blood Sugar What Guarantee Comes With Hiring And Keeping Employees In Your Medical Practice? Lytec And Practice Partner Medical Billing Software Medical alarm systems- a highly advanced tool to help you in emergency Get the necessary drug treatment from the rehab centers Medical Transcription Providers in Tulsa, OK